Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the göttingen minipig basal forebrain

Molecular Therapy

Volumn 18, Issue 12, 2010, Pages 2164-2172

  Fjord Larsen, Lone ^a   Kusk, Philip ^a   Tornøe, Jens ^a   Juliusson, Bengt ^a   Torp, Malene ^a   Bjarkam, Carsten R ^b   Nielsen, Mette S ^b   Handberg, Aase ^c   Sørensen, Jens Christian H ^c   Wahlberg, Lars U ^a  

^a NsGene AS   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; POLYETHERURETHAN; POLYVINYL ACETATE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BRAIN TISSUE; CELL COUNT; CELL LINE; CELL VIABILITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE MODEL; DNA MODIFICATION; DRUG DELIVERY SYSTEM; ENCAPSULATION; EXPLANT; FEMALE; FOREBRAIN; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MEMORY CONSOLIDATION; MINIPIG; NERVE CELL DEGENERATION; NONHUMAN; PIGMENT EPITHELIUM; PROTEIN PROCESSING; PROTEIN SECRETION; RAT;

ANIMALIA; SUIDAE;

EID: 78650874253     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.154     Document Type: Article

References (25)

1. Jönhagen, ME (2000). Nerve growth factor treatment in dementia. Alzheimer Dis Assoc Disord 14 (suppl 1): S31-S38.
2. Rosenberg, MB, Friedmann, T, Robertson, RC, Tuszynski, M, Wolff, JA, Breakefeld, XO et al. (1988). Grafting genetically modifed cells to the damaged brain: restorative effects of NGF expression. Science 242: 1575-1578.
3. Koliatsos, VE, Clatterbuck, RE, Nauta, HJ, Knüsel, B, Burton, LE, Hefti, FF et al. (1991). Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 30: 831-840.
4. Kordower, JH, Winn, SR, Liu, YT, Mufson, EJ, Sladek, JR Jr, Hammang, JP et al. (1994). The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91: 10898-10902.
5. Martínez-Serrano, A, Fischer, W, Söderström, S, Ebendal, T and Björklund, A (1996). Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain. Proc Natl Acad Sci USA 93: 6355-6360.
6. Conner, JM, Darracq, MA, Roberts, J and Tuszynski, MH (2001). Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci USA 98: 1941-1946.
7. Tuszynski, MH, Grill, R, Jones, LL, McKay, HM and Blesch, A (2002). Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts. J Comp Neurol 449: 88-101.
8. Li, LY, Li, JT, Wu, Q Y, Li, J, Feng, ZT, Liu, S et al. (2008). Transplantation of NGF-gene-modifed bone marrow stromal cells into a rat model of Alzheimer' disease. J Mol Neurosci 34: 157-163.
9. Seiger, A, Nordberg, A, von Holst, H, Bäckman, L, Ebendal, T, Alafuzoff, I et al. (1993). Intracranial infusion of purifed nerve growth factor to an Alzheimer patient: the frst attempt of a possible future treatment strategy. Behav Brain Res 57: 255-261.
10. Eriksdotter JM et al. (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9, 246-257.
11. Tuszynski, MH, Thal, L, Pay, M, Salmon, D P, U, HS, Bakay, R et al. (2005). A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11: 551-555.
12. Bishop, KM, Hofer, EK, Mehta, A, Ramirez, A, Sun, L, Tuszynski, M et al. (2008). Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons. Exp Neurol 211: 574-584.
13. Lindvall, O and Wahlberg, LU (2008). Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Exp Neurol 209: 82-88.
14. Dunn, KC, Aotaki-Keen, AE, Putkey, FR and Hjelmeland, LM (1996). ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62: 155-169.
15. Hoffman, D, Breakefeld, XO, Short, MP and Aebischer, P (1993). Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 122: 100-106.
16. Emerich, DF, Winn, SR, Harper, J, Hammang, J P, Baetge, EE and Kordower, JH (1994). Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349: 148-164.
17. Lindner, MD, Kearns, CE, Winn, SR, Frydel, B and Emerich, DF (1996). Effects of intraventricular encapsulated hNGF-secreting fbroblasts in aged rats. Cell Transplant 5: 205-223.
18. Greene, LA and Tischler, AS (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73: 2424-2428.
19. Sheehan, D and Hrapchak, B (1980). Theory and Practice of Histotechnology, Surgical Pathology - Histology, Staining Manual - Minerals and Pigments. pp. 226-227. Battelle Press, Ohio.
20. Schwenter, F, Bouche, N, Pralong, WF and Aebischer, P (2004). In vivo calcium deposition on polyvinyl alcohol matrix used in hollow fber cell macroencapsulation devices. Biomaterials 25: 3861-3868.
21. Suter, U, Heymach, JV Jr and Shooter, EM (1991). Two conserved domains in the NGF propeptide are necessary and suffcient for the biosynthesis of correctly processed and biologically active NGF. EMBO J 10: 2395-2400.
22. Winn, SR, Hammang, JP, Emerich, DF, Lee, A, Palmiter, RD and Baetge, EE (1994). Polymer-encapsulated cells genetically modifed to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 91: 2324-2328.
23. Fjord-Larsen, L, Johansen, JL, Kusk, P, Tornøe, J, Grønborg, M, Rosenblad, C et al. (2005). Effcient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modifed Neurturin construct. Exp Neurol 195: 49-60.
24. Bjarkam, CR, Cancian, G, Larsen, M, Rosendahl, F, Ettrup, KS, Zeidler, D et al. (2004). A MRI-compatible stereotaxic localizer box enables high-precision stereotaxic procedures in pigs. J Neurosci Methods 139: 293-298.
25. Bjarkam, CR, Cancian, G, Glud, AN, Ettrup, KS, Jørgensen, RL and Sørensen, JC (2009). MRI-guided stereotaxic targeting in pigs based on a stereotaxic localizer box ftted with an isocentric frame and use of SurgiPlan computer-planning software. J Neurosci Methods 183: 119-126.